RNAi compound targeted to thrombospondin-1 and applications thereof

貢獻的翻譯標題: 第一型血小板活化素siRNA分子及其應用

Ming-Derg Lai (Inventor)

研究成果: Patent

摘要

The present invention relates to an RNAi compound and an expression plasmid for inhibiting expression of Thrombospondin-1, which comprises a target sequence selected from Thrombospondin-1 gene. The present invention also related to a pharmaceutical composition comprising the RNAi compound and applications thereof. The RNAi compound can reduce the expression of Thrombospondin-1 to activate immune responses.
貢獻的翻譯標題第一型血小板活化素siRNA分子及其應用
原文English
專利號8377902
出版狀態Published - 2011 七月 7

指紋 深入研究「第一型血小板活化素siRNA分子及其應用」主題。共同形成了獨特的指紋。

引用此